[NFS-01] Neuroscience Frontier Symposium 01

[NFS-01-3] Making sense of energy imbalance in ALS

Shyuan T. Ngo (The University of Queensland, Australia)

A/Prof Ngo is a Group Leader at The University of Queensland. She leads a research program that aims to define the contribution of altered metabolic homeostasis to ALS pathophysiology and pathobiology. Her research integrates studies in ALS patients with studies in human-derived cell models (including stem cell-derived neurons, and human primary myosatellite cells and myotubes) and mouse models of ALS. Projects aim to decipher the molecular drivers of ALS, and to identify therapeutic strategies for the disease. The translational nature of her research has led to the expediting of therapeutics into clinical trials.

A/Prof Ngo has a career total of 70 manuscripts, 4 book chapters, and 1 dataset. Her overall field weighted citation impact (FWCI) is 2.29. She has >3500 citations and a h index = 29. She has received >AU$12M in salary, research grant and equipment grant funding. As a leading researcher in the field, she has received invitations to speak at several national and international conferences including: International Conference on Physiological Sciences (2016, Beijing), 6th Colombian Meeting of Physiology (2017, Medellin), ComBio 2018 (Sydney), ANS 2019 (Adelaide), 33rd International ALS/MND Symposium (2022, virtual), 64th Japanese Society of Neurology Meeting (2023, Tokyo)